As global demand for safe, high-quality medicines continues to grow, pharmaceutical manufacturers increasingly seek access to international procurement programs operated by organizations such as UNICEF, UNFPA, the Global Fund, and international development agencies.
One of the most important pathways to entering these markets is through the World Health Organization (WHO) Prequalification Programme (PQ).
WHO Prequalification serves as a globally recognized quality assurance mechanism that evaluates whether medicines meet international standards for quality, safety, and efficacy. For pharmaceutical manufacturers across Africa, achieving WHO prequalification can open doors to significant procurement opportunities while strengthening their global credibility.
Ultra Dynamic Quality Systems (UDQS) supports pharmaceutical organizations in preparing for WHO prequalification through structured regulatory strategies, GMP compliance programs, and technical documentation support.
Understanding the WHO Prequalification Programme
The WHO Prequalification Programme was established to ensure that medicines supplied through international procurement agencies meet internationally accepted quality standards.
Under this programme, WHO evaluates pharmaceutical products based on several critical components, including:
- Quality of the pharmaceutical product
- Manufacturing facility compliance with GMP
- Bioequivalence and clinical data
- Stability and product performance
- Regulatory documentation and dossiers
Products that successfully pass the evaluation are included in the WHO Prequalified List of Medicines, which procurement agencies rely upon when purchasing medicines for global health programs.
Why WHO Prequalification Matters
For pharmaceutical manufacturers, achieving WHO prequalification provides several strategic advantages.
Access to Global Procurement Market
Many international health programs procure medicines exclusively from manufacturers whose products are WHO prequalified.
These procurement programs represent billions of dollars in annual purchases of medicines for diseases such as:
- HIV/AIDS
- Tuberculosis
- Malaria
- Maternal and reproductive health medicines
- Vaccines and biologics
Manufacturers that achieve WHO prequalification gain access to these important markets.
Strengthened Regulatory Credibility
WHO prequalification is widely recognized as a mark of quality and regulatory excellence.
Manufacturers with prequalified products often find it easier to obtain approvals from national regulatory authorities in multiple countries.
This recognition can significantly accelerate market expansion.
Improved Quality Systems
The process of preparing for WHO prequalification requires organizations to strengthen their quality systems, manufacturing processes, and regulatory documentation.
As a result, companies often emerge from the process with stronger operational systems and improved production reliability.
Key Requirements for WHO Prequalification
Manufacturers seeking WHO prequalification must satisfy several critical requirements.
GMP-Compliant Manufacturing Facilities
Manufacturing facilities must comply with WHO GMP guidelines and undergo inspection by WHO assessors.
These inspections evaluate:
- Facility design and cleanliness
- Production processes
- Quality control laboratories
- Documentation systems
- Personnel training
- Data integrity practices
Facilities must demonstrate consistent compliance with international GMP standards.
Product Dossier Submission
Manufacturers must submit a comprehensive product dossier describing the pharmaceutical product in detail.
This dossier typically includes:
- Product formulation
- Manufacturing processes
- Analytical methods
- Stability studies
- Bioequivalence data
- Packaging and labeling information
The dossier is reviewed by WHO experts to ensure the product meets international quality standards.
Bioequivalence Studies
For generic pharmaceutical products, manufacturers must demonstrate that their product is bioequivalent to the reference product.
Bioequivalence studies confirm that the generic medicine performs in the body in the same way as the original product.
Ongoing Compliance and Monitoring
Even after achieving prequalification, manufacturers must maintain compliance with WHO standards.
WHO conducts periodic inspections and monitors product performance to ensure that quality standards continue to be met.
Challenges Faced by Emerging Manufacturers
Pharmaceutical manufacturers in emerging markets often face challenges when pursuing WHO prequalification.
Common challenges include:
- Incomplete GMP systems
- Limited regulatory documentation experience
- Insufficient validation data
- Weak data integrity controls
- Inadequate stability studies
Addressing these challenges requires careful planning and technical expertise.
The UDQS Approach to WHO Prequalification
Ultra Dynamic Quality Systems (UDQS) assists pharmaceutical manufacturers through every stage of the prequalification process.
Key support services include:
- GMP gap assessments against WHO standards
- Development and strengthening of Quality Management Systems
- Validation and qualification programs
- Regulatory dossier preparation
- Data integrity system implementation
- Inspection readiness preparation
By combining regulatory knowledge with practical operational experience, UDQS helps organizations navigate the complex pathway toward WHO prequalification.
Strengthening Pharmaceutical Manufacturing in Africa
As African countries invest in expanding local pharmaceutical production, achieving internationally recognized quality standards becomes increasingly important.
WHO prequalification provides a clear pathway for manufacturers to demonstrate compliance with global regulatory expectations while gaining access to international procurement markets.
Organizglobal healthcare supply chain.
Start Your WHO Prequalification Journey
Ultra Dynamic Quality Systems (UDQS) supports pharmaceutical manufacturers across Africa in building the technical and regulatory foundations required for WHO prequalification.
ations that successfully achieve prequalification position themselves as trusted partners in the
Whether your organization is strengthening its GMP systems, preparing regulatory dossiers, or planning new pharmaceutical products, UDQS can provide the expertise needed to successfully navigate the prequalification process.
